Ascendis Pharma A (ASND) Capital Leases (2012)

Ascendis Pharma A (ASND) reported Capital Leases of $274941.3 for Q4 2012.

Ascendis Pharma A (ASND) Capital Leases (2012) Analysis & Trends

Ascendis Pharma A (ASND) has 1 years of Capital Leases data on file, last reported at $274941.3 in Q4 2012.

For the quarter ending Q4 2012, Capital Leases changed N/A year-over-year to $274941.3; the trailing twelve-month figure through Dec 2012 stood at $274941.3 (changed N/A YoY), and the FY2012 full-year result was $272581.3, changed N/A from the prior year.
Capital Leases held at $274941.3 in Q4 2012.
In the past five years, Capital Leases ranged from a high of $274941.3 in Q4 2012 to a low of $274941.3 in Q4 2012.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Ascendis Pharma A	15.31 Bn	14.64 Bn	268.20 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2012	274,941.27